Mahindra Manulife Large & Mid Cap Fund Direct Growth

Mahindra Manulife Large & Mid Cap Fund Direct Growth is an equity fund. This fund was started on 1 January, 2020. The fund is managed by Manish Lodha. The fund could potentially beat inflation in the long-run.

1. Mahindra Manulife Large & Mid Cap Fund Direct Growth has ₹2765 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
2. The fund has an expense ratio 0.5.
   

Mahindra Manulife Large & Mid Cap Fund Direct Growth has given a CAGR return of 22.18% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 2.42%, 22.56% and 26.80% respectively.

Mahindra Manulife Large & Mid Cap Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Financial Services, Health, Industrial, Tech, Basic Materials, Communication, Consumer Cyclical, Utilities, Energy, Real Estate, Consumer Defensive. Its top holdings are Indus Towers Ltd Ordinary Shares, Divi's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Laurus Labs Ltd, UltraTech Cement Ltd

As it is a large & mid-cap mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

The investment objective of the Scheme is to seek long term capital growth through investments in equity and equity related securities of both large cap and mid cap stocks. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 500.00. Mahindra Manulife Large & Mid Cap Fund Direct Growth has no lock in period.